No Data
Cohen & Steers Announces Changes to Realty Indexes
Express News | GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse Nkt Cell Agonists for the Treatment of Inflammatory Conditions
GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Inflammatory Conditions
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Ascendiant Capital Maintains Buy on GRI Bio, Lowers Price Target to $40
H.C. Wainwright Maintains GRI Bio(GRI.US) With Buy Rating, Cuts Target Price to $10